SCHEMBL308533

SCHEMBL308533

CN(C)CCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL1034234 0.96
Hydrochloric Acid SCHEMBL15993093 0.96
SCHEMBL896593 0.77
SCHEMBL15275350 0.75
Hydrochloric Acid SCHEMBL19922527 0.74
SCHEMBL9491702 0.74
Iodide SCHEMBL296056 0.74
SCHEMBL29165313 0.72 ALDH1A1 (0.69)
SCHEMBL10425918 0.71 CA12 (0.73)
SCHEMBL4658729 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116239562-B Method for synthesizing doxepin hydrochloride by taking benzofuranone as raw material 江苏师范大学 2024-12-31 CN claimed
CN-116239562-A Method for synthesizing doxepin hydrochloride by taking benzofuranone as raw material 江苏师范大学 2023-06-09 CN claimed
CN-108164455-A The synthetic method of pheniramine maleate 广东众生药业股份有限公司 2018-06-15 CN claimed
US-20260035361-A1 COMPOUNDS FOR MODULATING HUR (ELAVL1) SHANGHAI DEGRON BIOMEDICAL TECH CO LTD (CN) 2026-02-05 US disclosed
EP-4626880-A1 COMPOUNDS FOR MODULATING HUR (ELAVL1) Shanghai Degron Biomedical Technology Co., Ltd. (CN) 2025-10-08 EP disclosed
CN-119431406-A Tricyclic compounds and medical uses thereof 正大天晴药业集团股份有限公司 2025-02-14 CN disclosed
CN-118373832-B Macrocyclic compound, pharmaceutical composition and application thereof 深圳晶蛋生物医药科技有限公司 2025-01-28 CN disclosed
CN-116239562-B Method for synthesizing doxepin hydrochloride by taking benzofuranone as raw material 江苏师范大学 2024-12-31 CN disclosed
WO-2024153028-A1 MACROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF 深圳晶蛋生物医药科技有限公司 2024-07-25 WO disclosed
CN-118373832-A Macrocyclic compound, pharmaceutical composition and application thereof 深圳晶蛋生物医药科技有限公司 2024-07-23 CN disclosed
WO-2024114639-A1 COMPOUNDS FOR MODULATING HUR (ELAVL1) SHANGHAI DEGRON BIOMEDICAL TECHNOLOGY CO., LTD. (CN) 2024-06-06 WO disclosed
US-4584290-A MICROBIOCIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-04-22 US disclosed
US-4560704-A SILANE ANCUORING;ATTACHING LIGAUD TO MATRIX PURDUE RESEARCH FOUNDATION (US) 1985-12-24 US disclosed
US-4549023-A ANTINFLAMMATORY AGENTS, ANALGESICS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-10-22 US disclosed
US-4533731-A ANTIINFLAMMATORY AGENTS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-08-06 US disclosed
US-4474964-A 3-Aminoindazole derivatives ASAHI, KASEI, KOGYO, KABUSHIKI, KAISHA (JP) 1984-10-02 US disclosed
EP-0111281-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-06-20 EP disclosed
EP-0090972-A2 Indazole derivatives Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1983-10-12 EP disclosed
EP-0049779-A1 3-Aminoindazole derivatives and process for preparation thereof Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-04-21 EP disclosed
US-3950343-A PYRROLOISOQUINOLINE DERIVATIVES AYERST, MCKENNA AND HARRISON LTD. (CA) 1976-04-13 US disclosed